Hepatitis
94
9
9
59
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
19 trials with published results (20%)
Research Maturity
59 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
4 terminated out of 94 trials
93.7%
+7.1% vs benchmark
20%
19 trials in Phase 3/4
32%
19 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (94)
ePro Diary - HDV ( MACROLIVER )
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
Acute Hepatitis in Pediatrics
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
A Partial Randomized, Single-blind or Open-label, Dose-escalation With Multiple-dose Design Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With Panadol® and SafeTynadol® in Healthy Volunteers
Collections of Blood and Stool Samples in Patients With Acute Hepatitis
Immune Cell Dysfunction in Severe Alcoholic Hepatitis
To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose
Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
The Living With a Long-Term Condition Study
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.